Jin Medical International Ltd.
ZJYL
$1.85
-$0.13-6.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.40M | 5.40M | 4.94M | 4.94M | 6.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.40M | 5.40M | 4.94M | 4.94M | 6.47M |
| Cost of Revenue | 3.55M | 3.55M | 3.67M | 3.67M | 3.57M |
| Gross Profit | 1.85M | 1.85M | 1.27M | 1.27M | 2.91M |
| SG&A Expenses | 841.40K | 841.40K | 1.10M | 1.10M | 1.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 33.90K | 33.90K | 65.20K | 65.20K | 23.10K |
| Total Operating Expenses | 4.87M | 4.87M | 5.17M | 5.17M | 5.27M |
| Operating Income | 531.20K | 531.20K | -227.10K | -227.10K | 1.20M |
| Income Before Tax | 783.60K | 783.60K | 14.30K | 14.30K | 1.09M |
| Income Tax Expenses | 97.50K | 97.50K | 9.80K | 9.80K | 227.40K |
| Earnings from Continuing Operations | 686.10K | 686.10K | 4.50K | 4.50K | 857.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.00K | -46.00K | -49.00K | -49.00K | 83.20K |
| Net Income | 640.20K | 640.20K | -44.50K | -44.50K | 940.90K |
| EBIT | 531.20K | 531.20K | -227.10K | -227.10K | 1.20M |
| EBITDA | 587.30K | 587.30K | -161.50K | -161.50K | 1.26M |
| EPS Basic | 0.08 | 0.08 | -0.01 | -0.01 | 0.12 |
| Normalized Basic EPS | 0.06 | 0.06 | -0.01 | -0.01 | 0.10 |
| EPS Diluted | 0.08 | 0.08 | -0.01 | -0.01 | 0.12 |
| Normalized Diluted EPS | 0.06 | 0.06 | -0.01 | -0.01 | 0.10 |
| Average Basic Shares Outstanding | 7.83M | 7.83M | 7.83M | 7.83M | 7.83M |
| Average Diluted Shares Outstanding | 7.83M | 7.83M | 7.83M | 7.83M | 7.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |